Piramal Pharma Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2024".
Piramal Pharma Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2024".